Cells · 2021
Different Lipid Signature in Fibroblasts of Long-Chain Fatty Acid Oxidation Disorders.
СтатьяПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Alatibi Khaled I, Hagenbuchner Judith, Wehbe Zeinab, Karall Daniela, Ausserlechner Michael J, Vockley Jerry, Spiekerkoetter Ute, Grünert Sarah C, Tucci Sara
Аннотация
Long-chain fatty acid oxidation disorders (lc-FAOD) are a group of diseases affecting the degradation of long-chain fatty acids. In order to investigate the disease specific alterations of the cellular lipidome, we performed undirected lipidomics in fibroblasts from patients with carnitine palmitoyltransferase II, very long-chain acyl-CoA dehydrogenase, and long-chain 3-hydroxyacyl-CoA dehydrogenase. We demonstrate a deep remodeling of mitochondrial cardiolipins. The aberrant phosphatidylcholine/phosphatidylethanolamine ratio and the increased content of plasmalogens and of lysophospholipids support the theory of an inflammatory phenotype in lc-FAOD. Moreover, we describe increased ratios of sphingomyelin/ceramide and sphingomyelin/hexosylceramide in LCHAD deficiency which may contribute to the neuropathic phenotype of LCHADD/mitochondrial trifunctional protein deficiency.
Предметные рубрики MeSH
Acyl-CoA Dehydrogenase, Long-ChainCardiolipinsCarnitine O-PalmitoyltransferaseCase-Control StudiesCells, CulturedCeramidesFatty AcidsFemaleFibroblastsHumansLipid Metabolism, Inborn ErrorsLipidomicsLong-Chain-3-Hydroxyacyl-CoA DehydrogenaseMaleMetabolism, Inborn ErrorsMetabolomeOxidation-ReductionSkinSphingolipidsTandem Mass Spectrometry